Clin2
NCT07758335Possibly a fitRecruiting

Probiotics and trace elements for ulcerative colitis

Ulcerative Colitis (UC)

Part of Digestive system clinical trials.

This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
132 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with mild to moderate ulcerative colitis.
  • You are currently on a biologic therapy (like infliximab) for your ulcerative colitis.
  • You have not taken probiotics or trace elements in the past month.
  • You do not have other serious health conditions like autoimmune diseases, liver cirrhosis, chronic kidney disease, or colorectal cancer.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07619638Recruiting
Microbiome Supplement for Mild-to-Moderate Ulcerative Colitis

This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.

Izmir
NCT07640659Not yet recruiting
Breath Tests to Study Gut Changes in Ulcerative Colitis

This study uses simple breath tests to measure changes in your gut during dietary treatment for ulcerative colitis. It may help doctors understand why some people respond better to dietary changes and guide future treatment decisions.

Kelowna, British Columbia
NCT06749795Not yet recruiting· Phase 1
A study of LIV001 for mild-to-moderate ulcerative colitis

This trial tests an investigational drug called LIV001 in people with mild-to-moderate ulcerative colitis. It aims to see if the medicine can help calm inflammation in the colon and improve symptoms.

Wroclaw
NCT07744646Not yet recruiting· Phase 1
Study of an experimental tablet for moderate to severe ulcerative colitis

This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.

Hefei, Anhui
NCT07427017Recruiting· Phase 2
Selenium for Ulcerative Colitis Patients on Biologics

This trial tests whether taking selenium supplements can help people with moderate to severe ulcerative colitis that is being treated with advanced therapies (biologics). The goal is to see if selenium can improve symptoms and reduce inflammation.

Chicago, Illinois
NCT07742410Not yet recruiting
Stool tests before colonoscopy for ulcerative colitis monitoring

This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.

Hear when a new Ulcerative Colitis (UC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.